Peter K. Sorger

Harvard University - Laboratory of Systems Pharmacology

MA

United States

SCHOLARLY PAPERS

2

DOWNLOADS

19

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Targeting Vulnerabilities in Successive Cell Cycle Stages to Induce Death of PI3K-Activated Basal-Like Breast Cancer Cells

Number of pages: 63 Posted: 31 Oct 2018
Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Department of Biological Chemistry and Molecular Pharmacology, Harvard University - Department of Biological Chemistry and Molecular Pharmacology, Harvard University - Department of Biological Chemistry and Molecular Pharmacology and Harvard University - Laboratory of Systems Pharmacology
Downloads 10 (587,347)

Abstract:

Loading...

2.

Multi-Omics Profiling Establishes the Polypharmacology of FDA Approved CSK4/6 Inhibitors and Its Impact on Drug Response

Number of pages: 61 Posted: 17 Nov 2018
Harvard University - Department of Systems Biology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Laboratory of Systems Pharmacology, Harvard University - Termeer Center for Targeted Therapies, Harvard University - Laboratory of Systems Pharmacology and Harvard University - Laboratory of Systems Pharmacology
Downloads 9 (593,721)

Abstract:

Loading...

Therapeutics, targeted therapy; HR breast cancer; CDK4/6 inhibitors; drug profiling; drug mechanisms of action